QSAR study of flavonoid derivatives as p56lck tyrosinkinase inhibitors

被引:27
|
作者
Thakur, A [1 ]
Vishwakarma, S [1 ]
Thakur, M [1 ]
机构
[1] Softvis Inst Biotechnol, Dept Chem, Indore, India
关键词
QSAR; flavonoid derivatives; p56lck protein tyrosinekinase; Hydration energy; logP;
D O I
10.1016/j.bmc.2003.11.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
QSAR studies on 104 flavonoid derivatives as p561ck protein tyrosinekinase inhibitors were performed using hydration energy and logP as predictor parameters. The results obtained demonstrate in detail, which specify that hydration energy and hydrophobic parameters of the compounds play a significant role in developing QSAR models. The significance of presence and absence of substituents on particular position is successfully explored with the help of indicator parameters. The results are critically discussed on the basis of multiple linear regression parameters. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1209 / 1214
页数:6
相关论文
共 50 条
  • [1] QSAR study of benzothiazole derivatives as p56lck inhibitors
    Badiger, Aravind M.
    Noolvi, Malleshappa N.
    Nayak, P. Vasudeva
    LETTERS IN DRUG DESIGN & DISCOVERY, 2006, 3 (08) : 550 - 560
  • [2] 3D-QSAR and Pharmacophore Identification of Benzothiazole Derivatives as Potent p56lck Inhibitors
    Arora, Kanika
    Khokra, Sukhbir Lal
    Khan, Shah Alam
    Husain, Asif
    CHIANG MAI JOURNAL OF SCIENCE, 2018, 45 (02): : 1062 - 1072
  • [3] QSAR study of p56lck protein tyrosine kinase inhibitory activity of flavonoid derivatives using MLR and GA-PLS
    Fassihi, Afshin
    Sabet, Razieh
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2008, 9 (09) : 1876 - 1892
  • [4] 4D-QSAR Study of p56lck Protein Tyrosine Kinase Inhibitory Activity of Flavonoid Derivatives Using MCET Method
    Yilmaz, Hayriye
    Guzel, Yahya
    Onal, Zulbiye
    Altiparmak, Gokce
    Kocakaya, Safak Ozhan
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2011, 32 (12) : 4352 - 4360
  • [5] 3D-QSAR STUDY OF BENZOTHIAZOLE DERIVATIVES AS p56(lck) INHIBITORS
    Mohmed, Jaheer
    Nalikala, Shruti
    Gunda, Shravan Kumar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (03): : 1139 - 1148
  • [6] PROTEINS ASSOCIATED WITH P56LCK
    SRINIVAS, PR
    HARRISON, ML
    FASEB JOURNAL, 1991, 5 (04): : A801 - A801
  • [7] The development of novel and selective p56lck tyrosine kinase inhibitors
    Bullington, JL
    Cameron, JC
    Davis, JE
    Dodd, JH
    Harris, CA
    Henry, JR
    Pellegrino-Gensey, JL
    Rupert, KC
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (18) : 2489 - 2494
  • [8] p56lck与T细胞发育
    田兰,陈慰峰
    生命科学, 1995, (01) : 11 - 15
  • [9] Inhibition of p56lck tyrosine kinase by isothiazolones
    Trevillyan, JM
    Chiou, XG
    Ballaron, SJ
    Tang, QM
    Buko, A
    Sheets, MP
    Smith, ML
    Putman, CB
    Wiedeman, P
    Tu, N
    Madar, D
    Smith, HT
    Gubbins, EJ
    Warrior, UP
    Chen, YW
    Mollison, KW
    Faltynek, CR
    Djuric, SW
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 364 (01) : 19 - 29
  • [10] Retinal dysplasia in mice lacking p56lck
    Omri, B
    Blancher, C
    Neron, B
    Marty, MC
    Rutin, J
    Molina, TJ
    Pessac, B
    Crisanti, P
    ONCOGENE, 1998, 16 (18) : 2351 - 2356